The most commonly reported adverse effects are gastrointestinal, including nausea, diarrhoea, vomiting, and constipation
Exendin-4 derivatives remain an important therapeutic option, particularly for patients requiring injectable therapy alongside metformin or other oral agents
Design and Baseline Characteristics of the FLOW Trial of Semaglutide in Patients With Type 2 Diabetes and Chronic Kidney Disease If this sounds like dj vu, that may be because Novo Nordisk previously implied that FLOW was positive on October 10 , 202 3 , when the trial was stopped early for efficacy (Figure 2)
Research suggests it encourages the breakdown of stored fat without significantly affecting blood sugar or acting through the IGF-1 pathway
Does Mounjaro Cause Nightmares
The research also reinforces that retatrutide is not designed to create overnight results